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SUMMARY
This Statement of Position provides guidance to practitioners
in conducting and reporting on an agreed-upon procedures
engagement performed pursuant to the AICPA Statements on
Standards for Attestation Engagements to assist a health
care provider in evaluating the effectiveness of its corporate
compliance program consistent with the requirements of a
Corporate Integrity Agreement (CIA) entered into with the
Office of Inspector General (OIG) of the U.S. Department
of Health and Human Services. CIAs are specific to the entity
involved; consequently, users of this SOP should be familiar
with the specific requirements of the entity's CIA.

Guidance to Practitioners in
Conducting and Reporting on an
Agreed-Upon Procedures Engagement
to Assist Management in Evaluating
the Effectiveness of Its Corporate
Compliance Program
Introduction and Background
1.

Within the past several years, the health care industry has
experienced a significant increase in the number and magnitude of allegations of fraud and abuse involving federal
health care programs (for example, Medicare and Medicaid) and private health care insurance. These allegations
have triggered regulatory scrutiny, litigation, significant
monetary settlements, and negative publicity related to—
among other things—coding and billing practices, patient
referrals, cost reporting, quality of care, and clinical practices. Typically, as part of the global resolution of these
allegations, the entity enters into a Corporate Integrity
Agreement (CIA) with the Office of Inspector General
(OIG) of the U.S. Department of Health and Human Services. Such agreements require that management annually report on its compliance with the terms of the CIA
and that there be an assessment of the entity's compliance
with the CIA. This assessment includes a billing analysis,
which may be performed by an independent review
organization (such as a practitioner or consultant) or the
provider (if permitted by the OIG), and an agreed-upon
procedures engagement.

2.

This Statement of Position (SOP) provides guidance to
practitioners in conducting and reporting on an agreedupon procedures engagement performed pursuant to the
American Institute of Certified Public Accountants (AICPA)
Statements on Standards for Attestation Engagements

(SSAEs) to assist an entity in evaluating the effectiveness
of its corporate compliance program consistent with the
requirements of a CIA.1 The terms of a CIA are unique to
the entity; consequently, users of this SOP need to be familiar with the actual CIA and its requirements.
3.

This SOP applies to agreed-upon procedures engagements
to assist in evaluating an entity's compliance for a specified
period. Such engagements should follow the AICPA attestation standards, including SSAE No. 1, Attestation Standards (AICPA, Professional Standard, vol. 1, AT sec. 100);
SSAE No. 3, Compliance Attestation (AICPA, Professional
Standards, vol. 1, AT sec. 500); and SSAE No. 4,AgreedUpon Procedures Engagements (AICPA, Professional
Standards, vol. 1, AT sec. 600). The engagement should be
conducted in accordance with standards established by the
AICPA,
including the criteria set forth in this SOP. However,
this SOP is not intended to provide all the required criteria
set forth in individual CIAs, nor all the applicable standards established by the AICPA. Additionally, the SOP contains some guidance that may be applied in evaluating an
organization's corporate compliance program, even though
the program was not imposed by a CIA.

Overview of a Typical Corporate
Integrity Agreement
4.

A CIA is an agreement between a health care provider and
the OIG in conjunction with a global settlement of a fraud
investigation. Such an agreement typically seeks to establish
a compliance program within the health care provider (for
example, hospital, clinical lab, physician group) that will
promote compliance with the requirements of Medicare,
Medicaid, and all other federal health care programs.

1. The practitioner also might be engaged to assist in other areas beyond an agreed-upon
procedures engagement such as providing consulting services in connection with evaluating the company's billing practices, policies, and procedures as required by the CIA
or in implementing, assessing, and reporting on voluntarily adopted compliance programs. In addition, the practitioner may assist in preparing an entity's self-disclosure
reports to federal health agencies related to billing errors and other compliance matters.
Similarly, practitioners may be involved in an entity's preparation of governmentrequired (but not CIA-imposed) compliance reporting (for example, contract requirements for Medicare part C) beyond an agreed-upon procedures engagement.
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5.

CIAs are case-specific. Their terms are tailored to address
the organizational and operating deficiencies related to
providing and billing for health care services that have
been identified by the OIG, the entity, or others. Detailed
compliance requirements are imposed as a condition for
continued participation in federal health care programs.
A sample CIA, provided by the OIG and intended to identify potential requirements, is included in appendix A,
"Sample Corporate Integrity Agreement." Typical agreements cover five years and require the entity to address
the following areas:
• Appointment of a compliance officer and establishment of a compliance committee
•

Establishment of a code of conduct

•

Establishment of policies and procedures regarding
the compliance program

•

Development of an information and education program as to CIA requirements, compliance program and
code of conduct

• Annual assessment of billing policies, procedures,
and practices
•

Establishment of a confidential disclosure program

•

Prohibition of employment of excluded or convicted
persons

•

Notification to OIG of investigation or legal proceedings

•

Reporting of credible evidence of misconduct

• Notifications to OIG of new provider locations
•

Provision of implementation and annual reports

•

Proper notification and submission of required
reports

•

Granting of OIG access to documents and individuals
to conduct assessments

•

Documentation of record retention requirements

• Awareness of disclosure criteria

• Agreement to comply with certain default provisions,
penalties, and remedies
•

Review of rights as to dispute resolution

•

Review of effective and binding agreement clauses

Conditions for Engagement Performance
6.

A practitioner may perform an agreed-upon procedures engagement related to management's compliance with a CIA if
all of the conditions specified in AT sec. 600.10 of SSAE No.
4 and AT sec. 500.09 through 500.11 of SSAE No. 3 are met.

7.

As discussed more fully in the SSAEs noted in paragraph 6,
Management's assertions as to its compliance must be capable of evaluation against reasonable criteria that either
have been established by a recognized body or are stated in
or attached to the practitioner's report in a sufficiently
clear and comprehensive manner. Generally, to avoid confusion, management's assertions, which are based on the
specific terms of its CIA, should be attached to the practitioner's report. If the entity is not subject to a CIA, management may develop its assertions using the model CIA. A
sample based on the model CIA, which is not meant to be
all-inclusive, is included as appendix B, "Sample Statement
of Management's Assertions."

Establishing an Understanding With the Client
8.

The practitioner should document the understanding in the
working papers, preferably through a written communication
with the client, such as an engagement letter. Appendix G,
"Sample Engagement Letter," contains a sample engagement
letter that may be used for this kind of engagement.

Users' Responsibilities
9.
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Users typically would be the management of the health
care provider and the OIG. Management is responsible for
ensuring that the entity complies with the requirements of
the CIA. That responsibility encompasses (a) identifying
applicable compliance requirements, (b) establishing and
maintaining internal control policies and procedures to

provide reasonable assurance that the entity complies with
those requirements, (c) evaluating and monitoring the entity's compliance, and (d) preparing reports that satisfy
legal, regulatory, or contractual requirements. Management's evaluation may include documentation such as accounting or statistical data, policy manuals, accounting
manuals, narrative memoranda, procedural write-ups,
flowcharts, completed questionnaires, internal auditors' reports, and other special studies or analyses. The form and
extent of documentation will vary depending on the nature
of the compliance requirements and the size and complexity of the entity. Management may engage the practitioner
to gather information to assist it in evaluating the entity's
compliance. Regardless of the procedures performed by
the practitioner, management must accept responsibility
for its assertions and must not base such assertions solely
on the practitioner's procedures.
10.

Specified users are responsible for the sufficiency (nature,
timing, and extent) of the agreed-upon procedures because
they best understand their own needs. The specified users assume the risk that such procedures might be insufficient for
their purposes. In addition, the specified users assume the
risk that they might misunderstand or otherwise inappropriately use findings properly reported by the practitioner.

Practitioner's Responsibilities
11.

The objective of the practitioner's agreed-upon procedures
is to present specific findings to assist users in evaluating
an entity's compliance with the requirements specified in
the CIA. (See appendix D, "Sample Procedures.")

12.

The practitioner's procedures generally may be as limited
or extensive as the specified users desire, as long as the
specified users agree upon the procedures performed or to
be performed and take responsibility for the sufficiency of
the agreed-upon procedures for their purposes.

13.

To satisfy the requirements that the practitioner and the
specified users agree upon the procedures performed or to
be performed and that the specified users take responsibility for the sufficiency of the agreed-upon procedures for
their purposes, ordinarily the practitioner should commu-

nicate directly with and obtain affirmative acknowledgment
from each of the specified users. For the purposes of these
engagements, an effective way to obtain this agreement
ordinarily is to distribute a draft of the report, detailing the
procedures, that is expected to be issued to the OIG with a
request for any comments it may have.
14.

To avoid possible misunderstandings, the practitioner
should circulate the draft with a legend stating that these
are the procedures expected to be performed, and unless
informed otherwise, the practitioner assumes that there
are no additional procedures that he or she is expected to
perform. A legend such as the following might be used.
This draft is furnished solely for the purpose of indicating the form of report that we would expect to be able to
furnish pursuant to the request by Management of
[Provider] for our performance of limited procedures relating to [Provider's] compliance with the Corporate Integrity Agreement with the Office of Inspector General
(OIG) of the U.S. Department of Heath and Human Services. Based on our discussions with [Provider], it is our
understanding that the procedures outlined in this draft
report are those we are expected to follow. Unless informed otherwise within ninety (90) days of this transmittal, we shall assume that there are no additional
procedures that we are expected to follow. The text of
the definitive report will depend, of course, on the results of the procedures.

Involvement of a Specialist2
15.

The practitioner's education and experience enable him or
her to be knowledgeable about business matters in general,
but he or she is not expected to have the expertise of a person trained for or qualified to engage in the practice of another profession or occupation. In certain circumstances,
it may be appropriate to involve a specialist to assist the
practitioner in the performance of one or more procedures.
The following are examples.

2. A specialist is a person (or firm) possessing special skill or knowledge in a particular
field other than the attest function. As used herein, a specialist does not include a person
employed by the practitioner's firm who participates in the attestation engagement.
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• An attorney might provide assistance concerning the
application of laws, regulations, or rules to a client's
situation.
• A medical specialist might provide assistance in understanding the characteristics of diagnosis codes
documented in patient medical records.
16.

The practitioner and the specified users should agree to the
involvement of a specialist in assisting a practitioner in the
performance of an agreed-upon procedures engagement.
This agreement may be reached when obtaining agreement
on the procedures performed or to be performed and acknowledgment of responsibility for the sufficiency of the
procedures, as discussed previously. The practitioner's report should describe the nature of the assistance provided
by the specialist.

17.

A practitioner may agree to apply procedures to the report
or work product of a specialist that does not constitute assistance by the specialist to the practitioner in an agreedupon procedures engagement. For example, the practitioner
may make reference to information contained in a report
of a specialist in describing an agreed-upon procedure.
However, it is inappropriate for the practitioner to agree to
merely read the specialist's report solely to describe or repeat the findings, or to take responsibility for all or a portion
of any procedures performed by a specialist or the specialist's work product.

Internal Auditors and Other Personnel 3
18.

The agreed-upon procedures to be enumerated or referred
to in the practitioner's report are to be performed entirely
by the practitioner except as discussed in paragraphs 16
through 18 of this SOP. However, internal auditors or other
personnel may prepare schedules, accumulate data, perform an internal assessment of management's compliance,
or provide other information for the practitioner's use in
performing the agreed-upon procedures.

3. SAS No. 65, The Auditor's Consideration of the Internal Audit Function in an Audit of
Financial Statements (AICPA, Professional Standards, vol. 1, AU sec. 322), does not
apply to agreed-upon procedures engagements.
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19.

A practitioner may agree to perform procedures on information documented in the working papers of internal auditors. For example, the practitioner may agree to—

20.

•

Repeat all or some of the procedures.

•

Determine whether the internal auditors' working
papers contain documentation of procedures performed and whether the findings documented in the
working papers are presented in a report by the internal auditors.

However, it is inappropriate for the practitioner to—
• Agree to merely read the internal auditor's report
solely to describe or repeat its findings.
•

Take responsibility for all or a portion of any procedures performed by internal auditors by reporting
those findings as the practitioner's own.

•

Report in any manner that implies shared responsibility for the procedures with the internal auditors.

Planning the Engagement
21.

Planning an agreed-upon procedures engagement involves
working with the users to develop an overall strategy for the
expected conduct and scope of the engagement. To develop
such a strategy, practitioners should have adequate technical training and proficiency in the attestation standards and
have adequate knowledge in health care regulatory matters
to enable them to sufficiently understand the events, transactions, and practices that, in their judgment, have a significant effect on the presentation of the assertions.

Working Papers
22.

The practitioner should prepare and maintain working papers in connection with an engagement under the attestation
standards; such working papers should be appropriate to
the circumstances and the practitioner's needs on the engagement to which they apply.
14

23.

Concern over access to the practitioner's working papers
might cause some clients to inquire about working paper requirements. In situations where the practitioner is requested
to not maintain copies of certain client documentation, or to
not prepare and maintain documentation similar to client
documents, the practitioner may refer to the auditing Interpretation, "Evidential Matter: Auditing Interpretation of Section 326" (AICPA, Professional Standards, vol. 1, AU sec.
9326.06-.17), for guidance. See the Attest Interpretation,
"Attestation Standards: Attestation Engagements Interpretations of Section 100" (AICPA, Professional Standards, vol.
1, AT sec. 9100.58), for guidance related to providing access
to or photocopies of working papers to a regulator in connection with work performed on an attestation engagement.

Management's Representations
24.

The practitioner should obtain written representation from
management on various matters including the following:
a. Acknowledging management's responsibility for complying with the CIA
b. Acknowledging management's responsibility for establishing and maintaining effective internal control over
compliance
c. Stating that management has performed an evaluation of the entity's compliance with CIA-specified
requirements
d. Stating management's assertions about the entity's
compliance with all aspects of the CIA, including the
specific issues that gave rise to the CIA4

4. Depending on the circumstances, representations in the following areas might be
appropriate.
- Violations or possible violations of laws or regulations, such as those related to the
Medicare and Medicaid antifraud and abuse statutes
- Compliance of third-party billings with applicable coding guidelines (for example,
IGD-9-CM, CPT) and laws and regulations (including medical necessity, proper approvals, and proper rendering of care)
- Proper filing of all required Medicare, Medicaid, and similar reports under the applicable reimbursement rules and regulations (including nature of costs—allowable,
patient-related, properly allocated, in accordance with applicable rules and regulations, properly adjusted to reflect prior audit adjustments) and adequacy of disclosures
(including disputed costs)
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e. Stating that management has disclosed to the practitioner all known noncompliance with the
CIA
f. Stating that management has made available all documentation relating to compliance with the CIA
g. Stating management's interpretation of any compliance requirements that have varying interpretations
h. Stating that management has disclosed any communication from regulatory agencies, internal auditors,
legal counsel, and other parties concerning matters
regarding the design, implementation, and monitoring
of the policies and procedures in place, including
communication received between the end of the
reporting period and the date of the practitioner's
report (the date of signature)
i. Stating that management has disclosed any known
noncompliance occurring subsequent to the end of
the reporting period
j.

Describing any related material fraud or abuse, other
fraud, abuse or illegal acts that, whether or not material, involve management or other employees who
have a significant role in the entity's design, implementation, and monitoring of the policies and procedures in place upon which compliance is based

k. Stating that management has disclosed to the practitioners, orally or in writing, information about past noncompliance issues covered in the settlement agreement that
gaveriseto the CIA and the related corrective measures
taken to support compliance in those areas
Management's refusal to furnish all appropriate written
representations constitutes a limitation on the scope of
the engagement sufficient to require withdrawal from the
engagement.

Reporting Considerations
25.
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A practitioner should present the results of applying
agreed-upon procedures to the specific subject matter in

the form of findings. The practitioner should not provide
negative assurance about whether the assertion is fairly
stated in accordance with established or stated criteria.
For example, the practitioner should not include a statement that "nothing came to my attention that caused me
to believe that the assertion is not fairly stated in accordance with (established or stated) criteria."
26.

The practitioner should report all findings from the application of the agreed-upon procedures. The concept of materiality does not apply to findings to be reported in an agreed-upon
procedures engagement unless the definition of materiality is
agreed to by the specified users. Any agreed-upon materiality
limits should be described in the practitioner's report.

27.

The practitioner has no obligation to perform procedures
beyond the agreed-upon procedures. However, if noncompliance related to management's assertion comes to the
practitioner's attention by other means, such information
ordinarily should be included in his or her report.

28.

The practitioner may become aware of noncompliance related to management's assertion that occurs subsequent to
the reporting period but before the date of the practitioner's report. The practitioner should consider including
information regarding such noncompliance in his or her report. However, the practitioner has no responsibility to
perform procedures to detect such noncompliance other
than obtaining management's representation about noncompliance in the subsequent period.

29.

The practitioner should follow the reporting guidance in
AT sec. 600.33 through 600.38 of SSAE 4. A sample report
is included in appendix E, "Sample Report."

30.

Evaluating compliance with certain requirements may require interpretation of the laws, regulations, rules, contracts,
or other agreements that establish those requirements. In
such situations, the practitioner should consider whether
he or she is provided with the reasonable criteria required
to evaluate an assertion under the third general attestation
standard. If these interpretations are significant, the practitioner may include a paragraph stating the description

and the source of interpretations made by the entity's management. An example of such a paragraph, which should
precede the procedures and findings paragraph(s), follows:
We have been informed that, under [name of entity's] interpretation of [identify the compliance requirement], [explain the nature and source of the relevant interpretation].
The date of completion of the agreed-upon procedures
should be used as the date of the practitioner's report.
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APPENDIX A
Sample Corporate Integrity Agreement
Corporate Integrity Agreement
Between the Office of Inspector General
of the Department of Health and
Human Services and [Provider]
I. Preamble
[Provider] ("[Provider]") hereby enters into this Corporate
Integrity Agreement ("CIA") with the Office of Inspector General ("OIG") of the United States Department of Health and
Human Services ("HHS") to ensure compliance by its employees with the requirements of Medicare, Medicaid and all other
Federal health care programs (as defined in 42 U.S.C. 1320a7b(f)) (hereinafter collectively referred to as the "Federal
health care programs"). [Provider's] compliance with the
terms and conditions in this CIA shall constitute an element
of [Provider's] present responsibility with regard to participation in the Federal health care programs. Contemporaneously
with this CIA, [Provider] is entering into a Settlement Agreement with the United States, and this CIA is incorporated by
reference into the Settlement Agreement.

II. Term of the CIA
The period of the compliance obligations assumed by
[Provider] under this CIA shall be 5 years from the effective
date of this CIA (unless otherwise specified). The effective
date of this CIA will be the date on which the final signatory
of this CIA executes this CIA (the "effective date").
Source: Office of the Inspector General of the United States Department of Health and
Human Services.
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Corporate Integrity Obligations
[Provider] shall establish a compliance program that includes the following elements.
A. Compliance Officer.
Within ninety (90) days after the effective date of this CIA,
[Provider] shall appoint an individual to serve as Compliance Officer, who shall be responsible for developing and
implementing policies, procedures, and practices designed
to ensure compliance with the requirements set forth in
this CIA and with the requirements of the Federal health
care programs. The Compliance Officer shall be a member
of senior management of [Provider], shall make regular (at
least quarterly) reports regarding compliance matters directly to the CEO and/or to the Board of Directors of
[Provider] and shall be authorized to report to the Board of
Directors at any time. The Compliance Officer shall be responsible for monitoring the day-to-day activities engaged
in by [Provider] to further its compliance objectives as
well as any reporting obligations created under this CIA. In
the event a new Compliance Officer is appointed during
the term of this CIA, [Provider] shall notify the OIG, in
writing, within fifteen (15) days of such a change.
[Provider] shall also appoint a Compliance Committee
within ninety (90) days after the effective date of this CIA.
The Compliance Committee shall, at a minimum, include the
Compliance Officer and any other appropriate officers as
necessary to meet the requirements of this CIA within the
provider's corporate structure (e.g., senior executives of each
major department, such as billing, clinical, human resources,
audit, and operations). The Compliance Officer shall chair
the Compliance Committee and the Committee shall support
the Compliance Officer in fulfilling his/her responsibilities.
B. Written Standards.
1. Code of Conduct Within ninety (90) days of the effective date of this CIA, [Provider] shall establish a Code of
Conduct. The Code of Conduct shall be distributed to all employees within ninety (90) days of the effective date of this
CIA. [Provider] shall make the promotion of, and adherence
20

to, the Code of Conduct an element in evaluating the performance of managers, supervisors, and all other employees. The Code of Conduct shall, at a minimum, set forth:
a. [Provider's] commitment to full compliance with all
statutes, regulations, and guidelines applicable to
Federal health care programs, including its commitment to prepare and submit accurate billings consistent with Federal health care program regulations
and procedures or instructions otherwise communicated by the Health Care Financing Administration
("HCFA") (or other appropriate regulatory agencies)
and/or its agents;
b. [Provider's] requirement that all of its employees
shall be expected to comply with all statutes, regulations, and guidelines applicable to Federal health care
programs and with [Provider's] own policies and procedures (including the requirements of this CIA);
c. the requirement that all of [Provider's] employees
shall be expected to report suspected violations of
any statute, regulation, or guideline applicable to
Federal health care programs or with [Provider's]
own policies and procedures;
d. the possible consequences to both [Provider] and to
any employee of failure to comply with all statutes,
regulations, and guidelines applicable to Federal
health care programs and with [Provider's] own policies and procedures or of failure to report such noncompliance; and
e. the right of all employees to use the confidential disclosure program, as well as [Provider's] commitment
to confidentiality and non-retaliation with respect to
disclosures.
Within ninety (90) days of the effective date of the CIA,
each employee shall certify, in writing, that he or she has
received, read, understands, and will abide by [Provider's]
Code of Conduct. New employees shall receive the Code of
Conduct and shall complete the required certification
within two (2) weeks after the commencement of their em-

ployment or within ninety (90) days of the effective date of
the CIA, whichever is later.
[Provider] will annually review the Code of Conduct and
will make any necessary revisions. These revisions shall be
distributed within thirty (30) days of initiating such a
change. Employees shall certify on an annual basis that
they have received, read, understand and will abide by the
Code of Conduct.
2. Policies and Procedures. Within ninety (90) days of the
effective date of this CIA, [Provider] shall develop and initiate implementation of written Policies and Procedures regarding the operation of [Provider's] compliance program
and its compliance with all federal and state health care
statutes, regulations, and guidelines, including the requirements of the Federal health care programs. At a minimum,
the Policies and Procedures shall specifically address [insert language relevant to allegations in the case]. In addition, the Policies and Procedures shall include disciplinary
guidelines and methods for employees to make disclosures
or otherwise report on compliance issues to [Provider]
management through the Confidential Disclosure Program
required by section III.E. [Provider] shall assess and update as necessary the Policies and Procedures at least annually and more frequently, as appropriate. A summary of
the Policies and Procedures will be provided to OIG in the
Implementation Report. The Policies and Procedures will
be available to OIG upon request.
Within ninety (90) days of the effective date of the CIA, the
relevant portions of the Policies and Procedures shall be
distributed to all appropriate employees. Compliance staff
or supervisors should be available to explain any and all
policies and procedures.
C. Training and Education.
1. General Training. Within ninety (90) days of the effective date of this CIA, [Provider] shall provide at least two
(2) hours of training to each employee. This general training shall explain [Provider's]:
a. Corporate Integrity Agreement requirements;
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b. Compliance Program (including the Policies and
Procedures as they pertain to general compliance
issues); and
c. Code of Conduct.
These training material shall be made available to the OIG,
upon request.
New employees shall receive the general training described
above within thirty (30) days of the beginning of their employment or within ninety (90) days after the effective date
of this CIA, whichever is later. Each year, every employee
shall receive such general training on an annual basis.
2. Specific Training. Within ninety (90) days of the effective date of this CIA, each employee who is involved directly or indirectly in the delivery of patient care and/or in
the preparation or submission of claims for reimbursement
for such care (including, but not limited to, coding and
billing) for any Federal health care programs shall receive
at least [insert number of training hours] hours of training
in addition to the general training required above. This
training shall include a discussion of:
a. the submission of accurate bills for services rendered
to Medicare and/or Medicaid patients;
b. policies, procedures and other requirements applicable to the documentation of medical records;
c. the personal obligation of each individual involved
in the billing process to ensure that such billings are
accurate;
d. applicable reimbursement rules and statutes;
e. the legal sanctions for improper billings; and
f. examples of proper and improper billing practices.
These training materials shall be made available to OIG,
upon request. Persons providing the training must be
knowledgeable about the subject area.
Affected new employees shall receive this training within
thirty (30) days of the beginning of their employment or
within ninety (90) days of the effective date of this CIA,

whichever is later. If a new employee has any responsibility
for the delivery of patient care, the preparation or submission of claims and/or the assignment of procedure codes
prior to completing this specific training, a [Provider] employee who has completed the substantive training shall
review all of the untrained person's work regarding the
assignment of billing codes.
Each year, every employee shall receive such specific
training on an annual basis.
3. Certification. Each employee shall certify, in writing,
that he or she has attended the required training. The certification shall specify the type of training received and the
date received. The Compliance Officer shall retain the certifications, along with specific course materials. These shall
be made available to OIG upon request.
D. Review Procedures.
[Provider] shall retain an entity, such as an accounting, auditing or consulting firm (hereinafter "Independent Review
Organization"), to perform review procedures to assist
[Provider] in assessing the adequacy of its billing and compliance practices pursuant to this CIA. This shall be an annual requirement and shall cover a twelve (12) month
period. The Independent Review Organization must have
expertise in the billing, coding, reporting and other requirements of the Federal health care programs from which
[Provider] seeks reimbursement. The Independent Review
Organization must be retained to conduct the assessment of
the first year within ninety (90) days of the effective date of
this CIA. For purposes of complying with this review procedures requirement, the OIG at its discretion, may permit
the [Provider] to utilize internal auditors to perform the review(s). In such case, the [Provider] will engage the Independent Review Organization to verify the propriety of the
internal auditors' methods and accuracy of their results.
The [Provider] will request the Independent Review Organization to produce a report on its findings which report
shall be included in the Annual Report to the OIG.
The Independent Review Organization (or the [Provider], if
permitted by the OIG, as set forth above) will conduct two
24

separate engagements. One will be an analysis of [Provider's]
billing to the Federal health care programs to assist the
[Provider] and OIG in determining compliance with all
applicable statutes, regulations, and directives/guidance
("billing engagement"). The second engagement will assist
the [Provider] and OIG in determining whether [Provider]
is in compliance with this CIA ("compliance engagement").
1. Billing Engagement The billing engagement shall consist
of a review of a statistically valid sample of claims for the
relevant period. The sample size shall be determined
through the use of a probe sample1. At a minimum, the full
sample must be within a ninety (90) percent confidence
level and a precision of twenty-five (25) percent. The probe
sample must contain at least thirty (30) sample units and
cannot be used as part of the full sample. Both the
probe sample and the sample must be selected through
random numbers. [Provider] shall use OIG's Office of
Audit Services Statistical Sampling Software, also known
as "RAT-STATS", which is available through the Internet at
www.hhs.gov/progorg/ratstat. html.
Each annual billing engagement analysis shall include the
following components in its methodology:
a. Billing Engagement Objective: Provide a statement
stating clearly the objective intended to be achieved
by the billing engagement and the procedure or combination of procedures that will be applied to achieve
the objective.
b. Billing Engagement Population: Identify the population, which is the group about which information
is needed. Explain the methodology used to develop the population and provide the basis for this
determination.
c. Sources of Data: Provide a full description of the source
of the information upon which the billing engagement
conclusions will be based, including the legal or other
standards applied, documents relied upon, payment
data, and/or any contractual obligations.
1. Probe sample is defined as a small, random preliminary sample.
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d. Sampling Unit: Define the sampling unit, which is
any of the designated elements that comprise the
population of interest.
e. Sampling Frame: Identify the sampling frame, which
is the totality of the sampling units from which the
sample will be selected.
As part of the billing engagement:
a. Inquire of management as to the procedures and controls affecting the billing process subject to the annual
assessment as specified in the CIA. Document that aspect of the billing process (e.g., flow of documents,
processing activities), and those controls that will be
tested in the sample. The documentation may consist
of flow charts, excerpts from policies and procedures
manuals, control questionnaires, etc.
b. Report the sample results, including the overall error
rate and the nature of the errors found (e.g., no documentation, inadequate documentation, assignment
of incorrect code).
c. Document findings related to [Provider's] procedures to correct inaccurate billings and codings to
the Federal health care programs and findings regarding the steps [Provider] is taking to bring its
operations into compliance or to correct problems
identified by the audit.
2. Agreed-upon Procedures or Compliance Engagement
An Independent Review Organization (or the [Provider], if
permitted by the OIG) shall also conduct an agreed-upon
procedures or compliance engagement, which shall assist
the users in determining whether [Provider's] program,
policies, procedures, and operations comply with the terms
of this CIA. This engagement shall include a section by section analysis of the requirements of this CIA.
A complete copy of the Independent Review Organization's
billing and agreed-upon procedures or compliance engagement shall be included in each of [Provider's] Annual Reports to OIG.
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3. Disclosure of Overpayments and Material Deficiencies.
If, as a result of these engagements, [Provider] or the Independent Review Organization identifies any billing, coding
or other policies, procedures and/or practices that result in
an overpayment, [Provider] shall notify the payor (e.g.,
Medicare fiscal intermediary or carrier) within 30 days of
discovering the deficiency or overpayment and take remedial steps within 60 days of discovery (or such additional
time as may be agreed to by the payor) to correct the problem, including preventing the deficiency from recurring.
The notice to the payor shall include:
a. a statement that the refund is being made pursuant
to this CIA;
b. a description of the complete circumstances surrounding the overpayment;
c. the methodology by which the overpayment was determined;
d. the amount of the overpayment;
e. any claim-specific information used to determine the
over-payment (e.g., beneficiary health insurance number, claim number, service date, and payment date);
f. the cost reporting period; and
g. the provider identification number under which the
repayment is being made.
If [Provider] determines an overpayment represents a material deficiency, contemporaneous with [Provider's] notification to the payor as provided above, [Provider] shall also
notify OIG of.
a. a complete description of the material deficiency;
b. amount of overpayment due to the material deficiency;
c. [Provider's] action(s) to correct and prevent such material deficiency from recurring;
d. the payor's name, address, and contact person where
the overpayment was sent;
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e. the date of the check and identification number (or
electronic transaction number) on which the overpayment was repaid.
For purposes of this CIA, an "overpayment" shall mean the
amount of money the provider has received in excess of
the amount due and payable under the Federal health care
programs' statutes, regulations or program directives, including carrier and intermediary instructions.
For purposes of this CIA, a "material deficiency" shall
mean anything that involves: (i) a substantial overpayment
or improper payment relating to the Medicare and/or Medicaid programs; (ii) conduct or policies that clearly violate
the Medicare and/or Medicaid statute, regulations or directives issued by HCFA and/or its agents; or (iii) serious quality of care implications for federal health care beneficiaries
or recipients. A material deficiency may be the result of an
isolated event or a series of occurrences.
4. Verification/Validation. In the event that the OIG determines that it is necessary to conduct an independent review
to determine whether or the extent to which [Provider] is
complying with its obligations under this CIA, [Provider]
agrees to pay for the reasonable cost of any such review or
engagement by the OIG or any of its designated agents.
E. Confidential Disclosure Program.
Within ninety (90) days after the effective date of this CIA,
[Provider] shall establish a Confidential Disclosure Program,
which must include measures (e.g., a toll-free compliance
telephone line) to enable employees, contractors, agents or
other individuals to disclose, to the Compliance Officer or
some other person who is not in the reporting individual's
chain of command, any identified issues or questions associated with [Provider's] policies, practices or procedures with
respect to the Federal health care program, believed by the
individual to be inappropriate. [Provider] shall publicize the
existence of the hotline (e.g., e-mail to employees or post
hotline number in prominent common areas).
The Confidential Disclosure Program shall emphasize a
non-retribution, non-retaliation policy, and shall include a
reporting mechanism for anonymous, confidential commu28

nication. Upon receipt of a complaint, the Compliance Officer (or designee) shall gather the information in such a way
as to elicit all relevant information from the individual reporting the alleged misconduct. The Compliance Officer (or
designee) shall make a preliminary good faith inquiry into
the allegations set forth in every disclosure to ensure that
he or she has obtained all of the information necessary to
determine whether a further review should be conducted.
For any disclosure that is sufficiently specific so that it reasonably: (1) permits a determination of the appropriateness
of the alleged improper practice, and (2) provides an opportunity for taking corrective action, [Provider] shall conduct
an internal review of the allegations set forth in such a disclosure and ensure that proper follow-up is conducted.
The Compliance Officer shall maintain a confidential disclosure log, which shall include a record and summary of
each allegation received, the status of the respective investigations, and any corrective action taken in response to
the investigation.
F. Ineligible Persons.
[Provider] shall not hire or engage as contractors any "Ineligible Person." For purposes of this CIA, an "Ineligible
Person" shall be any individual or entity who: (i) is currently excluded, suspended, debarred or otherwise ineligible to participate in the Federal health care programs; or
(ii) has been convicted of a criminal offense related to the
provision of health care items or services and has not been
reinstated in the Federal health care programs after a period of exclusion, suspension, debarment, or ineligibility.
Within ninety (90) days of the effective date of this CIA,
[Provider] will review its list of current employees and contractors against the General Services Administration's List
of Parties Excluded from Federal Programs (available
through the Internet at http://www.arnet.gov/epls) and the
HHS/OIG Cumulative Sanction Report (available through
the Internet at http://www.dhhs.gov/progorg/oig) to ensure
that it is not currently employing or contracting with any
Ineligible Person. Thereafter, [Provider] will review the list
once semi-annually to ensure that no current employees or
contractors are or have become Ineligible Persons.
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To prevent hiring or contracting with any Ineligible Person,
[Provider] shall screen all prospective employees and
prospective contractors prior to engaging their services by
(i) requiring applicants to disclose whether they are Ineligible Persons, and (ii) reviewing the General Services Administration's List of Parties Excluded from Federal Programs
(available through the Internet at http://www.arnet.gov/epls)
and the HHS/OIG Cumulative Sanction Report (available
through the Internet at http://www.dhhs.gov/progorg/oig).
If [Provider] has notice that an employee or agent is charged
with a criminal offense related to any Federal health care
program, or is suspended or proposed for exclusion during
his or her employment or contract with [Provider], within
10 days of receiving such notice [Provider] will remove
such employee from responsibility for, or involvement
with, [Provider's] business operations related to the Federal
health care programs until the resolution of such criminal
action, suspension, or proposed exclusion. If [Provider] has
notice that an employee or agent has become an Ineligible
Person, [Provider] will remove such person from responsibility for, or involvement with, [Provider's] business operations related to the Federal health care programs and shall
remove such person from any position for which the person's salary or the items or services rendered, ordered, or
prescribed by the person are paid in whole or in part, directly or indirectly, by Federal health care programs or
otherwise with Federal funds at least until such time as the
person is reinstated into participation in the Federal health
care programs.
G. Notification of Proceedings.
Within thirty (30) days of discovery, [Provider] shall notify
OIG, in writing, of any ongoing investigation or legal proceeding conducted or brought by a governmental entity or
its agents involving an allegation that [Provider] has committed a crime or has engaged in fraudulent activities or any
other knowing misconduct. This notification shall include a
description of the allegation, the identity of the investigating or prosecuting agency, and the status of such investigation or legal proceeding. [Provider] shall also provide
written notice to OIG within thirty (30) days of the resolu30

tion of the matter, and shall provide OIG with a description
of the findings and/or results of the proceedings, if any.
H. Reporting.
1. Credible evidence of misconduct. If [Provider ] discovers
credible evidence of misconduct from any source and, after
reasonable inquiry, has reason to believe that the misconduct may violate criminal, civil, or administrative law concerning [Provider's] practices relating to the Federal
health care programs, then [Provider] shall promptly report the probable violation of law to OIG. Defendants shall
make this disclosure as soon as practicable, but, not later
than thirty (30) days after becoming aware of the existence
of the probable violation. The [Provider's] report to OIG
shall include:
a. the findings concerning the probable violation, including the nature and extent of the probable violation;
b. [Provider's] actions to correct such probable violation; and
c. any further steps it plans to take to address such probable violation and prevent it from recurring.
To the extent the misconduct involves an overpayment,
the report shall include the information listed in section
III.D.3 regarding material deficiencies.
2. Inappropriate Billing. If [Provider] discovers inappropriate or incorrect billing through means other than the Independent Review Organization's engagement, the provider
shall follow procedures in section III.D.3 regarding overpayments and material deficiencies.

IV. New Locations
In the event that [Provider] purchases or establishes new
business units after the effective date of this CIA, [Provider]
shall notify OIG of this fact within thirty (30) days of the date
of purchase or establishment. This notification shall include
the location of the new operation(s), phone number, fax
number, Federal health care program provider number(s) (if
any), and the corresponding payor(s) (contractor specific)

that has issued each provider number. All employees at
such locations shall be subject to the requirements in this
CIA that apply to new employees (e.g., completing certifications and undergoing training).

V. Implementation and Annual Reports
A. Implementation Report.
Within one hundred and twenty (120) days after the effective date of this CIA, [Provider] shall submit a written report to OIG summarizing the status of its implementation
of the requirements of this CIA. This Implementation Report shall include:
1. the name, address, phone number and position description of the Compliance Officer required by section III.A;
2. the names and positions of the members of the Compliance Committee required by section III.A;
3. a copy of [Provider's] Code of Conduct required by
section III.B.1;
4. the summary of the Policies and Procedures required
by section III.B.2;
5. a description of the training programs required by
section III.C including a description of the targeted
audiences and a schedule of when the training sessions were held;
6. a certification by the Compliance Officer that:
a. the Policies and Procedures required by section III.B
have been developed, are being implemented, and
have been distributed to all pertinent employees ;
b. all employees have completed the Code of Conduct certification required by section III.B.1; and
c. all employees have completed the training and executed the certification required by section III.C.
7. a description of the confidential disclosure program
required by section III.E;
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8. the identity of the Independent Review Organization(s) and the proposed start and completion date
of the first audit; and
9. a summary of personnel actions taken pursuant to
section III.F.
B. Annual Reports.
[Provider] shall submit to OIG an Annual Report with respect to the status and findings of [Provider's] compliance
activities. The Annual Reports shall include:
1. any change in the identity or position description of
the Compliance Officer and/or members of the Compliance Committee described in section III .A;
2. a certification by the Compliance Officer that:
a. all employees have completed the annual Code of
Conduct certification required by section III.B.1;
and
b. all employees have completed the training and executed the certification required by section III.C.
3. notification of any changes or amendments to the
Policies and Procedures required by section III.B and
the reasons for such changes (e.g., change in contractor policy);
4. a complete copy of the report prepared pursuant to
the Independent Review Organization's billing and
compliance engagement, including a copy of the
methodology used.
5. [Provider's] response/corrective action plan to any issues raised by the Independent Review Organization.
6. a summary of material deficiencies reported throughout the course of the previous twelve (12) months
pursuant to III.D.3 and III.H.
7. a report of the aggregate overpayments that have
been returned to the Federal health care programs
that were discovered as a direct or indirect result of
implementing this CIA. Overpayment amounts should
be broken down into the following categories: Medicare,
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Medicaid (report each applicable state separately)
and other Federal health care programs;
8. a copy of the confidential disclosure log required by
section III.E;
9. a description of any personnel action (other than
hiring) taken by [Provider] as a result of the obligations in section III.F;
10. a summary describing any ongoing investigation or
legal proceeding conducted or brought by a government entity involving an allegation that [Provider]
has committed a crime or has engaged in fraudulent
activities, which have been reported pursuant to section III.G. The statement shall include a description
of the allegation, the identity of the investigating or
prosecuting agency, and the status of such investigation, legal proceeding or requests for information;
11. a corrective action plan to address the probable violations of law identified in section III.H; and
12. a listing of all of the [Provider's] locations (including
locations and mailing addresses), the corresponding
name under which each location is doing business, the
corresponding phone numbers and fax numbers, each
location's Federal health care program provider identification number(s) and the payor (specific contractor)
that issued each provider identification number.
The first Annual Report shall be received by the OIG no
later than one year and thirty (30) days after the effective
date of this CIA. Subsequent Annual Reports shall be submitted no later than the anniversary date of the due date of
the first Annual Report.
C. Certifications.
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The Implementation Report and Annual Reports shall include a certification by the Compliance Officer under
penalty of perjury, that: (1) [Provider] is in compliance with
all of the requirements of this CIA, to the best of his or her
knowledge; and (2) the Compliance Officer has reviewed the
Report and has made reasonable inquiry regarding its con-

tent and believes that, upon such inquiry, the information is
accurate and truthful.

VI. Notifications and Submission
of Reports
Unless otherwise stated in writing subsequent to the effective
date of this CIA, all notifications and reports required under
this CIA shall be submitted to the entities listed below:
OIG:
Civil Recoveries Branch—Compliance Unit
Office of Counsel to the Inspector General
Office of Inspector General
U.S. Department of Health and Human Services
Cohen Building, Room 5527
330 Independence Avenue, SW
Washington, DC 20201
Phone 202-619-2078; Fax 202-205-0604
[Provider]:
[Address and Telephone number of Provider's
Compliance Contact]

VII. OIG Inspection, Audit and
Review Rights
In addition to any other rights OIG may have by statute, regulation, or contract, OIG or its duly authorized representative(s), may examine [Provider's] books, records, and other
documents and supporting materials for the purpose of verifying and evaluating: (a) [Provider's] compliance with the
terms of this CIA; and (b) [Provider's] compliance with the
requirements of the Federal health care programs in which it
participates. The documentation described above shall be
made available by [Provider] to OIG or its duly authorized
representative(s) at all reasonable times for inspection, audit
or reproduction. Furthermore, for purposes of this provision,
OIG or its duly authorized representative(s) may interview
any of [Provider's] employees who consent to be inter-
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viewed at the employee's place of business during normal
business hours or at such other place and time as may be
mutually agreed upon between the employee and OIG.
[Provider] agrees to assist OIG in contacting and arranging
interviews with such employees upon OIG's request.
[Provider's] employees may elect to be interviewed with or
without a representative of [Provider] present.

VIII. Document and Record Retention
[Provider] shall maintain for inspection all documents and
records relating to reimbursement from the Federal health
care programs or to compliance with this CIA one year
longer than the term of this CIA (or longer if otherwise required by law).

IX. Disclosures
Subject to HHS's Freedom of Information Act ("FOIA") procedures, set forth in 45 C.F.R. Part 5, the OIG shall make a
reasonable effort to notify [Provider] prior to any release by
OIG of information submitted by [Provider] pursuant to its
obligations under this CIA and identified upon submission
by [Provider] as trade secrets, commercial or financial information and privileged and confidential under the FOIA
rules. [Provider] shall refrain from identifying any information as trade secrets, commercial or financial information
and privileged and confidential that does not meet the criteria for exemption from disclosure under FOIA.

X. Breach and Default Provisions
[Provider] is expected to fully and timely comply with all
of the obligations herein throughout the term of this CIA or
other time frames herein agreed to.
A. Stipulated Penalties for Failure to Comply with Certain
Obligations.
As a contractual remedy, [Provider] and OIG hereby agree
that failure to comply with certain obligations set forth in
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this CIA may lead to the imposition of the following monetary
penalties (hereinafter referred to as "Stipulated Penalties") in
accordance with the following provisions.
1. A Stipulated Penalty of $2,500 (which shall begin to
accrue on the day after the date the obligation became due) for each day, beginning 120 days after the
effective date of this CIA and concluding at the end of
the term of this CIA, [Provider] fails to have in place
any of the following:
a. a Compliance Officer,
b. a Compliance Committee;
c. a written Code of Conduct;
d. written Policies and Procedures;
e. a training program; and
f. a Confidential Disclosure Program;
2. A Stipulated Penalty of $2,500 (which shall begin to
accrue on the day after the date the obligation became
due) for each day [Provider] fails to meet any of the
deadlines to submit the Implementation Report or the
Annual Reports to the OIG.
3. A Stipulated Penalty of $2,000 (which shall begin to
accrue on the date the failure to comply began) for
each day [Provider]:
a. hires or contracts with an Ineligible Person after
that person has been listed by a federal agency as
excluded, debarred, suspended or otherwise ineligible for participation in the Medicare, Medicaid
or any other Federal health care program (as defined in 42 U.S.C. 1320a7b(f)). This Stipulated
Penalty shall not be demanded for any time period
if [Provider] can demonstrate that it did not discover the person's exclusion or other ineligibility
after making a reasonable inquiry (as described in
section III.F) as to the status of the person.
b. employs or contracts with an Ineligible Person and
that person: (i) has responsibility for, or involvement with, [Provider's] business operations related to the Federal health care programs or (ii) is
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in a position for which the person's salary or the
items or services rendered, ordered, or prescribed
by the person are paid in whole or in part, directly
or indirectly, by the Federal health care programs
or otherwise with Federal funds (this Stipulated
Penalty shall not be demanded for any time period
during which [Provider] can demonstrate that it
did not discover the person's exclusion or other
ineligibility after making a reasonable inquiry (as
described in III.F) as to the status of the person);
c. employs or contracts with a person who: (i) has
been charged with a criminal offense related to any
Federal health care program, or (ii) is suspended
or proposed for exclusion, and that person has responsibility for, or involvement with, [Provider's]
business operations related to the Federal health
care programs (this Stipulated Penalty shall not be
demanded for any time period before 10 days after
[Provider] received notice of the relevant matter
or after the resolution of the matter).
4. A Stipulated Penalty of $1,500 (which shall begin to
accrue on the date the [Provider] fails to grant access)
for each day [Provider] fails to grant access to the information or documentation as required in section V
of this CIA.
5. A Stipulated Penalty of $1,000 (which shall begin to
accrue ten (10) days after the date that OIG provides
notice to [Provider] of the failure to comply) for each
day [Provider] fails to comply fully and adequately
with any obligation of this CIA. In its notice to
[Provider], the OIG shall state the specific grounds for
its determination that the [Provider] has failed to
comply fully and adequately with the CIA obligation(s) at issue.
B. Payment of Stipulated Penalties.
1. Demand Letter. Upon a finding that [Provider] has failed
to comply with any of the obligations described in section
X.A and determining that Stipulated Penalties are appropriate, OIG shall notify [Provider] by personal service or certified mail of (a) [Provider's] failure to comply; and (b) the
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OIG's exercise of its contractual right to demand payment
of the Stipulated Penalties (this notification is hereinafter
referred to as the "Demand Letter").
Within fifteen (15) days of the date of the Demand Letter,
[Provider] shall either (a) cure the breach to the OIG's satisfaction and pay the applicable stipulated penalties, or (b)
request a hearing before an HHS administrative law judge
("ALJ") to dispute the OIG's determination of noncompliance, pursuant to the agreed-upon provisions set forth below
in section X.D. In the event [Provider] elects to request an
ALJ hearing, the Stipulated Penalties shall continue to accrue until [Provider] cures, to the OIG's satisfaction, the alleged breach in dispute. Failure to respond to the Demand
Letter in one of these two manners within the allowed time
period shall be considered a material breach of this CIA
and shall be grounds for exclusion under section X.C.
2. Timely Written Requests for Extensions. [Provider] may
submit a timely written request for an extension of time to
perform any act or file any notification or report required
by this CIA. Notwithstanding any other provision in this
section, if OIG grants the timely written request with respect to an act, notification, or report, Stipulated Penalties
for failure to perform the act or file the notification or report shall not begin to accrue until one day after [Provider]
fails to meet the revised deadline as agreed to by the OIGapproved extension. Notwithstanding any other provision
in this section, if OIG denies such a timely written request,
Stipulated Penalties for failure to perform the act or file the
notification or report shall not begin to accrue until two (2)
business days after [Provider] receives OIG's written denial
of such request. A "timely written request" is defined as a
request in writing received by OIG at least five (5) business
days prior to the date by which any act is due to be performed or any notification or report is due to be filed.
3. Form of Payment. Payment of the Stipulated Penalties
shall be made by certified or cashier's check, payable to "Secretary of the Department of Health and Human Services,"
and submitted to OIG at the address set forth in section VI.
4. Independence from Material Breach Determination. Except as otherwise noted, these provisions for payment of
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Stipulated Penalties shall not affect or otherwise set a standard for the OIG's determination that [Provider] has materially breached this CIA, which decision shall be made at
the OIG's discretion and governed by the provisions in section X.C, below.
C. Exclusion for Material Breach of this CIA.
1. Notice ofMaterial Breach and Intent to Exclude. The parties agree that a material breach of this CIA by [Provider]
constitutes an independent basis for [Provider's] exclusion
from participation in the Federal health care programs (as
defined in 42 U.S.C. 1320a7b(f)). Upon a determination by
OIG that [Provider] has materially breached this CIA and
that exclusion should be imposed, the OIG shall notify
[Provider] by certified mail of (a) [Provider's] material
breach; and (b) OIG's intent to exercise its contractual right
to impose exclusion (this notification is hereinafter referred
to as the "Notice of Material Breach and Intent to Exclude").
2. Opportunity to Cure. [Provider] shall have thirty-five
(35) days from the date of the Notice of Material Breach
and Intent to Exclude Letter to demonstrate to the OIG's
satisfaction that:
a. [Provider] is in full compliance with this CIA;
b. the alleged material breach has been cured; or
c. the alleged material breach cannot be cured within
the 35-day period, but that: (i) [Provider] has begun
to take action to cure the material breach, (ii)
[Provider] is pursuing such action with due diligence,
and (iii) [Provider] has provided to OIG a reasonable
timetable for curing the material breach.
3. Exclusion Letter. If at the conclusion of the thirty-five
(35) day period, [Provider] fails to satisfy the requirements
of section X.C.2, OIG may exclude [Provider] from participation in the Federal health care programs. OIG will notify
[Provider] in writing of its determination to exclude
[Provider] (this letter shall be referred to hereinafter as
the "Exclusion Letter"). Subject to the Dispute Resolution
provisions in section X.D, below, the exclusion shall go into
effect thirty (30) days after the date of the Exclusion Letter.
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The exclusion shall have national effect and will also apply
to all other federal procurement and non-procurement programs. If [Provider] is excluded under the provisions of
this CIA, [Provider] may seek reinstatement pursuant to
the provisions at 42 C.F.R. §§1001.3001-.3004.
4. Material Breach. A material breach of this CIA means:
a. a failure by [Provider] to report a material deficiency,
take corrective action and pay the appropriate refunds, as provided in section III.D;
b. repeated orflagrantviolations of the obligations under
this CIA, including, but not limited to, the obligations
addressed in section X.A of this CIA;
c. a failure to respond to a Demand Letter concerning
the payment of Stipulated Penalties in accordance
with section X.B above; or
d. a failure to retain and use an Independent Review
Organization for review purposes in accordance with
section III.D.
D. Dispute Resolution.
1. Review Rights. Upon the OIG's delivery to [Provider]
of its Demand Letter or of its Exclusion Letter, and as an
agreed-upon contractual remedy for the resolution of disputes arising under the obligation of this CIA, [Provider]
shall be afforded certain review rights comparable to the
ones that are provided in 42 U.S.C. §§1320a7(f) and 42
C.F.R. §1005 as if they applied to the Stipulated Penalties
or exclusion sought pursuant to this CIA. Specifically, the
OIG's determination to demand payment of Stipulated
Penalties or to seek exclusion shall be subject to review
by an ALJ and, in the event of an appeal, the Departmental Appeals Board ("DAB"), in a manner consistent
with the provisions in 42 C.F.R. §§1005.2-1005.2 1.
Notwithstanding the language in 42 C.F.R. §1005.2(c), the
request for a hearing involving stipulated penalties shall
be made within fifteen (15) days of the date of the Demand
Letter and the request for a hearing involving exclusion
shall be made within thirty (30) days of the date of the
Exclusion Letter.
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2. Stipulated Penalties Review. Notwithstanding any provision of Title 42 of the United States Code or Chapter 42 of
the Code of Federal Regulations, the only issues in a proceeding for stipulated penalties under this CIA shall be (a)
whether [Provider] was in full and timely compliance with
the obligations of this CIA for which the OIG demands payment; and (b) the period of noncompliance. [Provider]
shall have the burden of proving its full and timely compliance and the steps taken to cure the noncompliance, if
any. If the ALJ finds for the OIG with regard to a finding of
a breach of this CIA and orders [Provider] to pay Stipulated Penalties, such Stipulated Penalties shall become due
and payable twenty (20) days after the ALJ issues such a
decision notwithstanding that [Provider] may request review of the ALJ decision by the DAB.
3. Exclusion Review. Notwithstanding any provision of
Title 42 of the United States Code or Chapter 42 of the
Code of Federal Regulations, the only issues in a proceeding for exclusion based on a material breach of this CIA
shall be (a) whether [Provider] was in material breach of
this CIA; (b) whether such breach was continuing on the
date of the Exclusion Letter; and (c) the alleged material
breach cannot be cured within the 35-day period, but that
(i) [Provider] has begun to take action to cure the material
breach, (ii) [Provider] is pursuing such action with due
diligence, and (iii) [Provider] has provided to OIG a reasonable timetable for curing the material breach.
For purposes of the exclusion herein, exclusion shall take
effect only after an ALJ decision that is favorable to the
OIG. [Provider's] election of its contractual right to appeal
to the DAB shall not abrogate the OIG's authority to exclude [Provider] upon the issuance of the ALJ's decision. If
the ALJ sustains the determination of the OIG and determines that exclusion is authorized, such exclusion shall
take effect twenty (20) days after the ALJ issues such a decision, notwithstanding that [Provider] may request review
of the ALJ decision by the DAB.
4. Finality of Decision. The review by an ALJ or DAB provided for above shall not be considered to be an appeal right
arising under any statutes or regulations. Consequently, the
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parties to this CIA agree that the DAB's decision (or the
ALJ's decision if not appealed) shall be considered final for
all purposes under this CIA and [Provider] agrees to waive
any right it may have to appeal the decision administratively, judicially or otherwise seek review by any court or
other adjudicative forum.

XI. Effective and Binding Agreement
Consistent with the provisions in the Settlement Agreement
pursuant to which this CIA is entered, and into which this
A. This CIA shall be binding on the successors, assigns
and transferees of [Provider];
B. This CIA shall become final and binding on the date
the final signature is obtained on the CIA;
C. Any modifications to this CIA shall be made with the
prior written consent of the parties to this CIA; and
D. The undersigned [Provider] signatories represent
and warrant that they are authorized to execute this
CIA.
The undersigned OIG signatory represents that
he is signing this CIA in his official capacity and that
he is authorized to execute this CIA.
ON BEHALF OF [PROVIDER]
DATE
DATE
DATE

[Please identify all signatories]
ON BEHALF OF THE OFFICE OF INSPECTOR GENERAL
OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES
LEWIS MORIS

DATE

Assistant Inspector General for Legal Affairs
Office of Inspector General
U.S. Department of Health and Human Services
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APPENDIX B
Sample Statement of
Management's Assertions
[Date]
In connection with the Corporate Integrity Agreement (CIA)
entered into with the Office of the Inspector General of the
United States Department of Health and Human Services
dated [date], we make the following assertions, which are
true to the best of our knowledge and belief.

Governance
Within 90 days of the date of the CIA, we—
1. Established a Compliance Committee, which meets
at least monthly and requires a quorum to meet.
2. Appointed to our Compliance Committee members
who include at a minimum those individuals specified in the CIA.
3. Delegated to the Compliance Committee the authority to implement and monitor the CIA, as evidenced
by the organization chart or the Compliance Committee's charter.
4. Appointed a compliance officer, who reports directly
to the individual specified in the CIA.
We appointed a compliance officer who—
1. Has sufficient staff and resources to carry out his or
her responsibilities.
2. Actively participates in compliance training.
3. Has authority to conduct full and complete internal
investigations without restriction.
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4. Periodically revises the compliance program to meet
changing circumstances and risks.

Billing Practices, Policies, and Procedures
Although no system of internal controls can provide absolute assurance that all bills comply in all respects with
Medicare, Medicaid, and other federal health care program
guidelines, we are not aware of any material weaknesses in
our billing practices, policies, and procedures. Billings to
third-party payors comply in all material respects with
applicable coding principles and laws and regulations (including those dealing with Medicare and Medicaid antifraud
and abuse) and only reflect charges for goods and services
that were medically necessary, properly approved by regulatory bodies (e.g., the Food and Drug Administration), if
required and properly rendered. [Insert other assertions as
necessary to address matters covered in the CIA.] Any
Medicare, Medicaid, and other federal health program
billing deficiencies that we identified have been properly
reported to the applicable payor within 60 days of discovery of the deficiency.

Corporate Integrity Policy
1. Our policy was developed and implemented within
[number] days of execution of the CIA.
2. The policy addresses the Company's commitment to
preparation and submission of accurate billings consistent with the standards set forth in federal health
care program statutes, regulations, procedures and
guidelines or as otherwise communicated by Health
Care Financing Administration (HCFA), its agents or
any other agency engaged in the administration of the
applicable federal health care program.
3. The policy addressed the specific issues that gave rise
to the settlement, as well as other risk areas identified by the OIG in published Fraud Alerts issued
through [date].
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4. Further details on the development and implementation of our policy were provided to the OIG in our letter
dated [date].
5. Our policy was distributed to all employees, physicians and independent contractors involved in submitting or preparing requests for reimbursement.
6. We have prominently displayed a copy of our policy
on the Company's premises.

Information and Education Program
As discussed more fully in our letter to the OIG dated [date],
we conducted an Information and Education Program within
[number] days of the CIA. The Information and Education
Program requires that each officer, employee, agent and
contractor charged with administering federal health care
programs (including, but not limited to billers, coders,
nurses, physicians, medical records, hospital administration and other individuals directly involved in billing federal health care programs) receive at least [number] hours
of training.
The training provided to employees involved in billing, coding, and/or charge capture consisted of instructions on submitting accurate bills, the personal obligations of each
individual to ensure billings are accurate, the nature of
company-imposed disciplinary actions on individuals who
violate company policies and/or laws and regulations, applicable federal health care program rules, legal sanctions
against the company for submission of false or fraudulent information, and how to report potential abuses or fraud. The
training material addresses those issues underlying our settlement with the OIG.
The experience of the trainers is consistent with the topics
presented.

Confidential Disclosure Program
Our Confidential Disclosure Program—
1. Was established within [number] days of the CIA.

46

2. Enables any employee to disclose any practices or
billing procedures relating to federal health care
programs.
3. Provides a toll-free telephone line maintained by the
Company, which Company representatives have indicated is maintained twenty-four hours a day, seven
days a week, for the purpose of making any disclosures
regarding compliance with the Company's Compliance
Program, the obligations in the CIA, and Company's
overall compliance with federal and state standards.
4. Includes policies requiring the review of any disclosures to permit a determination of the appropriateness of the billing practice alleged to be involved and
any corrective action to be taken to ensure that
proper follow-up is conducted.
5. A detailed summary of the communications (including the number of disclosures by employees and the
dates of such disclosures) concerning billing practices
reported as, and found to be, inappropriate under the
Confidential Disclosure Program, and the results of
any internal review and the follow-up on such disclosures are summarized in Attachment [title] to our
Annual Report.

Excluded Individuals or Entities
Company policy—
1. Prohibits the employment of or contracting with an
individual or entity that is listed by a federal agency
as convicted of abuse or excluded, suspended or otherwise ineligible for participation in federal health care
programs.
2. Includes a process to make an inquiry into the status
of any potential employee or independent contractor.
3. Provides for an annual review of the status of all existing employees and contractors to verify whether
any individual had been suspended or excluded or
charged with a criminal offense relating to the provision of federal health care services.

We are not aware of any individuals employed in contravention of the prohibitions in the CIA.

Record Retention
Our record retention policy is consistent with the requirements of the CIA.
Signed by:
Chief Executive Officer
Chief Financial Officer
Corporate Compliance Officer
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APPENDIX C
Sample Engagement Letter
The following is an illustration of a sample engagement letter that may be
used for this kind of engagement.

[CPA Firm Letterhead]
[Client's Name and Address]
Dear

:

This will confirm our understanding of the arrangements for our performance of certain agreed-upon procedures in connection with management's compliance with the terms of the Corporate Integrity Agreement
(CIA) with the Office of Inspector General (OIG) of the U.S. Department
of Health and Human Services (HHS) dated [date of CIA] for the period

ending [date].
We will perform those procedures enumerated in the attachment to this
letter. Our responsibility is to carry out these procedures and report our
findings. We will conduct our engagement in accordance with standards
established by the American Institute of Certified Public Accountants.
Our planned procedures were agreed to by management and will be communicated to the OIG for its review and are based on the terms specified
in the CIA. The sufficiency of these procedures is solely the responsibility
of the specified users of the report. Consequently, it is understood that we
make no representation regarding the sufficiency of the procedures described in the attachment for the purpose for which this report has been
requested or for any other purpose.
Management is responsible for the Company's compliance with all applicable laws, regulations, and contracts and agreements, including the
CIA. Management also is responsible for the design, implementation,
and monitoring of the policies and procedures upon which compliance
is based.
Our engagement to perform agreed-upon procedures is substantially less
in scope than an examination, the objective of which is the expression of
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an opinion on management's compliance with the CIA. Accordingly, we
will not express such an opinion or any other form of assurance thereon.1
Working papers that are prepared in connection with this engagement
are the property of the independent accountant. The working papers
are prepared for the purpose of providing the principal support for the
independent accountant's report. At the completion of our work, we expect to issue an agreed-upon procedures report in the attached form.
If, however, we are not able to complete all of the specified procedures,
we will so advise you. At that time, we will discuss with you the form of
communication, if any, that you desire for our findings. We will ask you
to confirm your request in writing at that time. If you request that we
delay issuance of our report until corrective action is taken that will result in compliance with all aspects of the CIA, we will do so only at your
written request. Our working papers will be retained in accordance with
our firm's working paper retention policy.
The distribution of the independent accountant's report will be restricted
to the governing board and management of the Company and the OIG.
Our fees will be billed as work progresses and are based on the amount
of time required at various levels of responsibility plus actual out-ofpocket expenses. Invoices are payable upon presentation. We will notify
you immediately of any circumstances we encounter that could significantly affect our initial estimate of total fees.
We agree that to the extent required by law, we will allow the Comptroller General of the United States, HHS, and their duly authorized representatives to have access to this engagement letter and our documents
and records to the extent necessary to verify the nature and amount of
costs of the services provided to the Company, until the expiration of
four years after we have concluded providing services to the Company
that are performed pursuant to this Engagement Letter. In the event the
Comptroller General, HHS, or their duly authorized representatives
1. The independent accountant may wish to include an understanding with the client about
any limitation or other arrangements regarding liability of the practitioner or the client in
the engagement letter. For example, the following might be included in the letter:
Our maximum liability relating to services rendered under this letter (regardless of form of action, whether in contract, negligence or otherwise) shall be limited to the charges paid to us for the portion of the services or work products
giving rise to liability. We will not be liable for consequential or punitive damages (including lost profits or savings) even if aware of their possible existence.
You will indemnify us against any damage or expense that may result from any
third-party claim relating to our services or any use by you of any work product,
and you will reimburse us for all expenses (including counsel fees) as incurred
by us in connection with any such claim, except to the extent such claim (i) is
finally determined to have resulted from our gross negligence or willful misconduct or (ii) is covered by any of the preceding indemnities.
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request such records, we agree to notify the Company of such request as
soon as practicable.
In the event we are requested or authorized by the Company or are required by government regulation, subpoena, or other legal process to produce our documents or our personnel as witnesses with respect to our
engagements for the Company, the Company will, so long as we are not
a party to the proceeding in which the information is sought, reimburse
us for our professional time and expenses, as well as the fees and expenses of our counsel, incurred in responding to such requests.
If this letter correctly expresses your understanding of this engagement,
please sign the enclosed copy where indicated and return it to us. We
appreciate the opportunity to serve you.
Sincerely,
[Partner's Signature]
[Firm Name or Firm Representative]
Accepted and agreed to:
[Client Representative's Signature]
[Title]
[Date]
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APPENDIX D
Sample Procedures
Procedure
Governance
1. We read the Company's corporate minutes
and organization chart and ascertained
that, within [number] days of the date of
the Corporate Integrity Agreement (CIA),
the Company—
a. Established a Compliance Committee,
which is to meet meets at least monthly
and requires a quorum to meet.
b. Appointed to its Compliance Committee members who include, at a minimum, those individuals specified in
the CIA.
c. Delegated to the Compliance Committee the authority to implement and
monitor the CIA, as evidenced by the
organization chart or the Compliance
Committee's charter.
d. Appointed a compliance officer who
reports directly to the individual specified in the CIA.
2. We interviewed the compliance officer
and were informed that, in his or her opinion, the Compliance Officer—
a. Has sufficient staff and resources to
carry out his or her responsibilities.
b. Actively participates in compliance
training.
c. Has the authority to conduct full and
complete internal investigations without restriction.
d. Periodically revises the compliance
program to meet changing circumstances and risks.
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Findings

Procedure

Findings

3. We read the OIG notification letter as
specified in the CIA and noted that the appropriate official signed the letter, that it
was addressed to the OIG, that it covered
items (a) through (d) in Step 1, and that it
was dated within [number of] days of the
execution of the CIA.
Billing Practices, Policies,
and Procedures
The practitioner might be engaged to provide consulting services in connection with
the evaluation of the company's
billing
practices, policies, and procedures. If so,
generally no agreed-upon procedures would
be performed relating to this area.
Alternatively, if the procedures relating to
the Company's billing practices,
policies,
and procedures are performed by others
such as the Company's internal audit staff,
the practitioner performs Steps 4 through 9.
4. We read the compliance work plan and
noted the following.
a. The work plan's stated objectives include the determination that billings
are accurate and complete, for services
rendered that have been deemed by
medical specialists as being necessary,
and are submitted in accordance with
federal program guidelines.
b. The work plan sampling methodology
sets confidence levels consistent with
those defined in the CIA.
c. The work plan identifies risk areas, as
defined in the CIA (if applicable), and
specifies testing procedures by risk area.
d. The work plan specifies that samples
are taken in risk areas (if applicable)
identified by the CIA.
e. The work plan includes testing procedures, which the practitioner should
modify as required by the CIA, for the
following risks areas (if applicable)
identified in the
CIA
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Procedure
1) Clinical documentation, as follows:
i)

No documentation of service

ii) Insufficient documentation of
service
iii) Improper diagnosis or treatment plan giving rise to the
provision of a medically unnecessary service or treatment
iv) Service or treatment does not
conform medically with the
documented diagnosis or treatment plan
v) Services incorrectly coded
2) Billing and coding, as follows:
i)

Noncovered or unallowable
service

ii) Duplicate payment
iii) DRG window error
iv) Unbundling
v) Utilization
vi) Medicare credit balances
[Note to Practitioner: Modify the preceding
list as required by the CIA.]
5. We selected [quantity] probe samples
performed by the independent review organization for the following risk areas [list
risk areas tested]. For the probe samples
selected, we noted that the—
a. Sample patient billing files were randomly selected.
b. Sample size reflected confidence levels
specified in the CIA.
c. Sample plan describes how missing
items (if any) would be treated.
d. Patient billing files tested were pulled
per the listing of random numbers and
all patient billing files were accounted
for in the working papers.
e. Work plans for the specific sample
described the risk areas (if applicable)
being tested and the testing approach/
procedures.
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Procedure

Findings

f. Working papers noted the completion
of each work plan step.
g. Working papers contained a summary
of findings for the sample
6. We reperformed the work plan steps [list
of specific steps performed] for the sample
patient billing files. The reperformance of
work plan steps related to the medical review of the sample patient billing files was
performed by the following individuals
[note the professional qualifications of individuals without listing names]. Any exceptions between our findings and the
Company's are summarized in the Attachment to this report.
7. We read the summary findings of all internal compliance reviews that the Company's Internal Audit department indicated
it had performed for the Company and
noted that all material billing deficiencies
[ s p e c i f y material threshold as defined by
the Company] noted therein were discussed in written communications addressed to the appropriate payor (for
example, Medicare Part B carrier) and
were dated within 60 days from the time
the deficiency occurred.1
8. We inquired of [individual] as to whether
the Company took remedial steps within
[number of] days (or such additional time
as agreed to by the payor) to correct all
material billing deficiencies noted in Step
7. We were informed that such remedial
steps had been taken.
9. By reading applicable correspondence, we
noted that any material billing deficiencies noted in Step 7 were communicated
to the OIG, including specific findings relative to the deficiency, the Company's
actions taken to correct the deficiency,

1. The CIA provides it own legal definition of a "material deficiency." Determination of
whether a billing or other act meets this definition is normally beyond the auditor's
professional competence and may have to await final determination by a court of law.
Accordingly, to avoid confusion, a working definition different from that provided in the
CIA
(e.g., a specified dollar thresh
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Procedure
and any further steps the Company plans
to take to prevent any similar deficiencies from recurring.
Corporate Integrity Policy
10. We read the Company's Corporate Integrity
Policy and noted the following.
a. The policy was developed and implemented within [number of] days of execution of the CIA.
b. The policy addressed the Company's
commitment to preparation and submission of accurate billings consistent
with the standards set forth in federal
health care program statutes, regulations, procedures, and guidelines or as
otherwise communicated by HCFA, its
agents, or any other agency engaged in
the administration of the applicable
federal health care program.
c. The policy addressed the specific issues
that gave rise to the settlement, as well
as other risk areas identified by the
OIG in published Fraud Alerts issued
through [agency].
d. Correspondence addressed to the OIG
covered the development and implementation of the policy.
e. Documentation indicating that the policy was distributed to all employees,
physicians, and independent contractors involved in submitting or preparing requests for reimbursement.
f. The prominent display of a copy of the
policy on the Company's premises.
11. We selected a sample of ten employees
(involved in submitting and preparing requests for reimbursement) and examined
written confirmation in the employee's
personnel file indicating receipt of a copy
of the Corporate Integrity Policy.
Information and Education Program
12. We read the Company's Information and
Education Program and noted the following.
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a. The Information and Education Program agenda was dated within [number
of] days of execution of the CIA.
b. Correspondence covering the development and implementation of the Information and Education Program was
addressed to the OIG.
c. The Information and Education Program requires that each officer, employee, agent, and contractor charged
with administering federal health care
programs (including, but not limited
to billers, coders, nurses, physicians,
medical records, hospital administration and other individuals directly involved in billing federal health care
programs) receive at least [number of]
hours of training.
13. We selected a sample of ten employees
involved in billing, coding and/or charge
capture and examined sign-in logs of the
training classes and noted that each had
signed indicating that they had received
at least [number of] hours of training as
specified in the Information and Education
Program. We also reviewed tests and surveys completed by each of the ten trained
employees noting evidence that they
were completed.
14. We inquired as to the training of individuals not present during the regularly scheduled training programs and were informed
that each such individual is trained either
individually or in a separate make-up session. We inquired as to the names of individuals not initially present and selected
one such individual and examined that
individual's post-training test and survey
for completion.
15. We read the course agenda and noted that
the training provided to employees involved in billing, coding, and/or charge
capture consisted of instructions on submitting accurate bills, the personal obligations of each individual to ensure billings
are accurate, the nature of company-
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imposed disciplinary actions on individuals who violate company policies and/or
laws and regulations applicable to federal
health care program rules, legal sanctions
against the company for submission of
false or fraudulent information, and how
to report potential abuses or fraud. We
also noted that the training material addressed the following issues which gave
rise to the settlement [practitioner list].
16. We inquired of the Corporate Compliance
Officer as to the qualifications and experience of the trainers and were informed
that, in the Corporate Compliance Officer's opinion, they were consistent with
the topics presented.
17. We noted that the Company's draft Annual
Report to the OIG dated [date] addresses
certification of training.
Confidential Disclosure Program
18. We read documentation of the Company's
Confidential Disclosure Program and noted
that it—
a. Includes the printed effective date
that was within [number of] days of
execution of the CIA.
b. Consists of a confidential disclosure
program enabling any employee to
disclose any practices or billing procedures relating to federal health care
programs.
c. Provides a toll-free telephone line maintained by the Company, which Company representatives have indicated is
maintained twenty-four hours a day,
seven days a week, for the purpose of
making any disclosures regarding compliance with the Company's Compliance Program, the obligations in the
CIA, and Company's overall compliance with federal and state standards.
d. Includes policies requiring the review
of any disclosures to permit a determination of the appropriateness of the
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billing practice alleged to be involved
and any corrective action to be taken
to ensure that proper follow-up is conducted.
19. We made five test calls to the toll free
telephone line (hotline) and noted the
following.
a. Each call was captured in the hotline
logs and reported with all other incoming calls.
b. Anonymity is not discouraged.
20. We noted that the Company included in
its draft Annual Report addressed to OIG
dated [date] a detailed summary of the
communications (including the number
of disclosures by employees and the dates
of such disclosures) concerning billing
practices reported as, and found to be,
inappropriate under the Confidential Disclosure Program, and the results of any
internal review and the follow-up on such
disclosures.
21. We observed the display of the Company's
Confidential Disclosure Program, including notice of the availability of its hotline,
on the Company's premises.
Excluded Individuals or Entities
22. We read the Company's written policy relating to dealing with excluded or convicted persons or entities and noted that
the policy—
a. Prohibits the hiring of or contracting
with an individual or entity that is
listed by a federal agency as convicted
of abuse or excluded, suspended, or
otherwise ineligible for participation
in federal health care programs.
b. Includes a process to make an inquiry
into the status of any potential employee or independent contractor.
c. Provides for a semi-annual review of
the status of all existing employees and
contractors to verify whether any individual had been suspended or excluded
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or charged with a criminal offense relating to the provision of federal health
care services.
23. We selected a sample of ten employees
hired over the course of the test period as
defined in the CIA and examined support
in the employee's personnel file documenting inquiries made into the status of
the employee, including documentation
of comparison to the [source specified in
the CIA].
24. We performed the following procedures
related to the Company's semi-annual
review of employee status.
a. Read documentation of the semi-annual review as evidence that a review
was performed.
b. Selected and reviewed the lesser of
ten or all exceptions and determined
that such employees were removed
from responsibility for or involvement with Provider business operations related to the Federal health
care programs.
c. Examined a notification letter addressed to the OIG and dated within
30 days of the employee's removal
from employment.
d. Inquired of [officer] as to whether he
or she was aware of any individuals
employed in contravention of the prohibitions in the CIA. If so, we further
noted that [indicate specific procedures] to confirm that such situation
was cured within 30 days by [indicate
how situation was cured].
Annual Report
25. We read the Company's draft Annual Report dated [date] and determined that it
included the following items, to be modified as appropriate, by the practitioner:
a. Compliance Program Charter and organization chart
b. Amendments to policies
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c. Detailed descriptions of reviews and
audits
d. Summary of hotline communications
e. Summary of annual review of employees
f. Cross-referencing to items noted in
the
CIA
Record Retention
26. We read the Company's record retention
policy and noted that it was consistent with
the requirements as outlined in the CIA.
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APPENDIX E
Sample Report
Independent Accountant's Report

[Date]
Sample Health Care Provider
Office of Inspector General of the
U.S. Department of Health and Human Services
We have performed the procedures enumerated in the Attachment,
which were agreed to by Sample Health Care Provider (Company) and
the Office of Inspector General (OIG) of the U.S. Department of Health
and Human Services, solely to assist the users in evaluating management's assertion about [name of entity's] compliance with the Corporate
Integrity Agreement (CIA) with the OIG dated [date of CIA] for the
[period] ending [date], which is included as Attachment A to this report.
This agreed-upon procedures engagement was performed in accordance
with standards established by the American Institute of Certified Public
Accountants. The sufficiency of these procedures is solely the responsibility of the specified users of the report. Consequently, we make no representation regarding the sufficiency of the procedures described in
Attachment B either for the purpose for which this report has been
requested or for any other purpose.
We were not engaged to and did not perform an examination, the objective of which would be the expression of an opinion on management's
compliance with the CIA. Accordingly, we do not express such an opinion. Had we performed additional procedures, other matters might have
come to our attention that would have been reported to you.
This report is intended solely for the information and use of the Compliance Committee and management of the Company and the OIG, and is
not intended to be and should not be used by anyone other than those
specified parties.

Include as Attachments the CIA and the summary that enumerates
procedures and findings.
[Signature]
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